People · Operator
Named in public records as an officer, director or promoter · active 2017–2025 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Angiex, Inc. | — | Biotechnology | Series B | $24.9M | $98.6M | 2017 |
Paul Jaminet at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Paul Jaminet on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Errik Anderson | 1 | 8 |
| Jonathan Adams | 1 | 7 |
| Jason Camm | 1 | 5 |
| Iain Dukes | 1 | 5 |
| Tina Neel | 1 | 1 |
| Fabian Hansen | 1 | 1 |
| Amal Amin | 1 | 1 |
| Haijing Guo | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.